AFP and hepatocellular carcinoma: Against this background, an attempt was made to unify the criteria for eligibility of HCC patients for LT based on an analysis of the results of nationwide data collection in Japan, leading to the development of the 5‐5‐500 criteria (tumor diameter 5 cm or less, tumor number 5 or less, and AFP 500 ng/mL or less).33